Earnings Feed
Start Free
Home/Filings/4/0001140361-22-035474
4//SEC Filing

Skyeline Management Ltd 4

Accession 0001140361-22-035474

CIK 0001802768other
View on SEC.govCompany Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:15 PM ET

Size

12.0 KB

Accession

0001140361-22-035474

Insider Transaction Report

Form 4
Period: 2022-09-28
Royalty Pharma plcRPRX
Giuliani Mario Germano
Director10% Owner
Transactions
  • Sale

    Class A Ordinary Shares

    2022-09-28$41.05/sh−32,593$1,337,943→ 8,077,140 total(indirect: See Footnotes)
Holdings

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    22,390,000

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    50,000

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    3,477,520
Skyeline Management Ltd
10% Owner
Transactions
  • Sale

    Class A Ordinary Shares

    2022-09-28$41.05/sh−32,593$1,337,943→ 8,077,140 total(indirect: See Footnotes)
Holdings

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    50,000

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    3,477,520

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    22,390,000
Avara Management Ltd
10% Owner
Transactions
  • Sale

    Class A Ordinary Shares

    2022-09-28$41.05/sh−32,593$1,337,943→ 8,077,140 total(indirect: See Footnotes)
Holdings

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    22,390,000

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    3,477,520

  • Class A Ordinary Shares

    (indirect: See Footnotes)
    50,000
Footnotes (5)
  • [F1]Reflects securities held directly by Skyeline Management Ltd. Skyeline Management Ltd is wholly-owned by Avara Management Ltd. Avara Management Ltd is wholly-owned by M. Germano Giuliani.
  • [F2]Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16.
  • [F3]Reflects securities held directly by MGG Strategic SICAF SIF S.A. - MGG Strategic, a Luxembourg company ("MGG Strategic"). MGG Strategic is a sub-fund managed and administered by MGG Strategic SICAF SIF S.A. ("MGG SICAF"). A board of directors consisting of M. Germano Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by MGG SICAF. Each member of the board disclaims beneficial ownership over such shares. MGG SICAF is owned by the MGG Trust of which M. Germano Giuliani is the beneficiary. The MGG Trust is the 100% economic owner of the shares held by MGG Strategic. M. Germano Giuliani disclaims beneficial ownership over the shares beneficially owned by MGG Strategic. The trustee of the MGG Trust is GISEV Trustees Limited. The protector of the MGG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the MGG Trust.
  • [F4]Reflects securities held by the spouse of M. Germano Giuliani.
  • [F5]Reflects securities held directly by Avara Management Ltd.

Documents

1 file

Issuer

Royalty Pharma plc

CIK 0001802768

→
Entity typeother
IncorporatedVirgin Islands, British

Related Parties

1
  • filerCIK 0001814877

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:15 PM ET
Size
12.0 KB
View on SEC.gov